Hostname: page-component-7bb8b95d7b-495rp Total loading time: 0 Render date: 2024-09-21T02:29:47.306Z Has data issue: false hasContentIssue false

Benzodiazepine withdrawal syndrome

Published online by Cambridge University Press:  02 January 2018

Malcolm Lader
Affiliation:
Institute of Psychiatry, De Crespigny Park, London SE5 8AF
Sally Morton
Affiliation:
Institute of Psychiatry, De Crespigny Park, London SE5 8AF
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1991 

References

Gallager, D. W. Heninger, K. & Heninger, G. (1986) Periodic benzodiazepine antagonist administration prevents benzodiazepine withdrawal symptoms in primates. European Journal of Pharmacology, 132, 3138.CrossRefGoogle ScholarPubMed
Golombok, S. Higgitt, A. Fonagy, P. et al (1987) A follow-up study of patients treated for benzodiazepine dependence. British Journal of Medical Psychology, 60, 141149.Google Scholar
Gonsalves, S. F. & Gallager, D. W. (1985) Spontaneous and Ro 15-1788-induced reversal of subsensitivity to GABA following chronic benzodiazepines. European Journal of Pharmacology, 110, 163170.CrossRefGoogle ScholarPubMed
Higgitt, A. Lader, M. H. & Fonagy, P. (1985) Clinical management of benzodiazepine dependence. British Medical Journal, 291, 688690.Google Scholar
Miller, L. G. Greenblatt, D. J. Roy, R. B. et al (1988) Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of γ-aminobutyric acidA receptor complex binding and function. Journal of Pharmacology and Experimental Therapeutics, 246, 177182.Google Scholar
Whitwam, J. G. (1988) Flumazenil: a benzodiazepine antagonist. British Medical Journal, 297, 9991000.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.